SPRINGFIELD, Ill. — H. D. Smith on Monday announced the winners of its annual Trading Partners of the Year award, honoring select pharmaceutical and health products manufacturers who collaborate actively to grow the industry and advance patient care. Each award category recognizes two winners, based on criteria including trade volume, trade policies and overall sales, for excellence across each key H. D. Smith product area.
This year’s Trading Partners of the Year are:
- Brand and Specialty Pharmaceuticals: AstraZeneca and Eisai;
- Generic Pharmaceuticals: Lupin Pharmaceuticals and Qualitest;
- Health, Beauty and Wellness Products: Geiss, Destin and Dunn and The Emerson Group; and
- Home Healthcare Products: First Quality and Allison Medical.
“H. D. Smith’s commitment to improving the quality, safety and cost of patient care goes hand-in-hand with building strong relationships with our industry partners,” said Chris Smith, president and COO of H. D. Smith. “Our mission and focus is providing best-in-class support for our manufacturing, pharmacy and health-system customers, and ultimately, the patients they care for across the country. Our connection with each trading partner is deeply valued, and because we know how much our partnership can benefit both organizations, we invite all trading partners to spend time with us each year. We collaborate and plan for the next year, together.”
The awards were presented during the 2014 H. D. Smith National Sales and Management Conference held Aug. 5-7 in Charleston, S.C.